Revolution Medicines
RVMD
RVMD
139 hedge funds and large institutions have $2.99B invested in Revolution Medicines in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
9% less funds holding
Funds holding: 152 → 139 (-13)
50% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 24
Holders
139
Holding in Top 10
8
Calls
$5.09M
Puts
$2.71M
Top Buyers
| 1 | +$49.4M | |
| 2 | +$34.8M | |
| 3 | +$25.8M | |
| 4 |
DM
Deerfield Management
New York
|
+$24.7M |
| 5 |
BlackRock
New York
|
+$21.2M |
Top Sellers
| 1 | -$53.5M | |
| 2 | -$19.3M | |
| 3 | -$13.4M | |
| 4 |
Goldman Sachs
New York
|
-$11.7M |
| 5 |
MGB
Mass General Brigham
Somerville,
Massachusetts
|
-$7.33M |